SWOT Analysis
- S
- W
- O
- T
Technical Analysis
Moving Averages
We appreciate your patience. Your content is on the way.
Current Price
- Bullish Moving Averages
- Bearish Moving Averages
Resistance and support
We appreciate your patience. Your content is on the way.
Company Financials
- Profit and loss statement
- Balance sheet
- Quarterly Result
- Ratio
We appreciate your patience. Your content is on the way.
Quick Results Snapshot
We appreciate your patience. Your content is on the way.
Stocks Comparison
Table
Chart
We appreciate your patience. Your content is on the way.
Corporate Action
- Announcement
- Board Meeting
- Dividend
- Split
- Rights
- Events
Insider & Institutional Activity
- Bulk Block Deals
- Insider Trading & SAST
We appreciate your patience. Your content is on the way.
About Evoq Remedies Ltd
Stock PE (TTM)
Promoter Holding
Book Value
ROCE
ROE
Evoq Remedies Limited was originally incorporated as "Salus Life Science and Research Private Limited" at Ahmedabad, Gujarat on February 24th, 2010 vide Certificate of Incorporation issued by Assistant Registrar of Companies, Gujarat, Dadra and Nagar Haveli. Subsequently, name of the Company was changed to "Evoq Remedies Private Limited" on July 15th, 2019 and upon its conversion into Public Company, the name was changed to "Evoq Remedies Limited" dated July 28th, 2021. Although Company was formed in 2010, it started operations from 2018 onwards. Company is a recognized trading house of Pharmaceuticals Raw Materials, Excipients, Bulk Drugs at affordable price catering to customers located in Ahmedabad. Company is engaged in pharmaceutical business involving marketing, trading and distribution of pharmaceutical formulation products such as antibiotic drugs, antimalarial drugs, antiallergic & anti cold drugs, analgesic/ antipyretic & anti inflammatory drugs, dermatology products, cerebral activator drugs, neurological drugs, gastrointestinal drugs, steroids, gynecology drugs, calcium, multivitamins, anti-oxidants and injections. The Company offer wide range of pharmaceuticals formulation products, of which around 120 products are marketed by them under their own brand name, the manufacturing of which is outsourced by them to third parties. Apart from pharmaceutical formulation products, we also deal in trading of active pharmaceutical ingredients (API`s). In areas like Pharmaceuticals Raw Materials, Excipients, Bulk Drugs etc., Company specializes in offering quality products and affordable trading in Gujarat. In the healthcare segment, the Company being into trading business, hence offers a wide basket of products. These pharmaceutical raw materials include both active pharmaceutical ingredients (APIs) and inactive ingredients or excipients. The Company made a public issue by allotting 36,00,000 equity shares and raised funds aggregating to Rs. 9.72 Crore in March, 2022.
Evoq Remedies share price as on 05 Dec 2025 is Rs. 3.1. Over the past 6 months, the Evoq Remedies share price has decreased by 26.19% and in the last one year, it has decreased by 61.01%. The 52-week low for Evoq Remedies share price was Rs. 2.11 and 52-week high was Rs. 9.28.
543500
INE0JVD01011
Sep
Evoq Remedies Ltd FAQs
You can buy Evoq Remedies Ltd shares through a brokerage firm. ICICIdirect is a registered broker through which you can place orders to buy Evoq Remedies Ltd Share.
Company share prices and volatile and keep changing according to the market conditions. As of Dec 05, 2025 10:46 AM the closing price of Evoq Remedies Ltd was Rs.3.10.
The latest PE ratio of Evoq Remedies Ltd as of Dec 05, 2025 10:46 AM is 75.00
The latest PB ratio of Evoq Remedies Ltd as of Dec 05, 2025 10:46 AM is 0.17
The 52-week high of Evoq Remedies Ltd share price is Rs. 9.28 while the 52-week low is Rs. 2.11
Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of Dec 05, 2025 10:46 AM, the market cap of Evoq Remedies Ltd stood at Rs. 7.72 Cr.
Market Outlook
View allWe appreciate your patience. Your content is on the way.